A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

This study has been withdrawn prior to enrollment.
(Study canceled based on results of different study with similar hypothesis, investigational agent, & patient)
Sponsor:
Information provided by (Responsible Party):
Centocor, Inc.
ClinicalTrials.gov Identifier:
NCT01266811
First received: December 23, 2010
Last updated: January 25, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)